– USA, CA – Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the appointment of Leslie Gillin to its Board of Directors, effective immediately.
“We are very pleased to welcome Leslie to the Board of Establishment Labs. She is extraordinarily accomplished in consumer marketing and finance, and her experience and insights will be invaluable as we continue to transform our industry by engaging directly with patients and by advancing new business and payment models,” commented Founder and CEO, Juan José Chacón-Quirós.
About Leslie Gillin
Leslie Gillin has spent the last 30 years in senior marketing, product management, and business development roles. She is currently the Chief Growth Officer of Pagaya. Pagaya is a financial technology company leveraging sophisticated AI-driven credit and analysis technology to enable the credit industry to deliver its customers a positive experience while simultaneously enhancing the broader credit ecosystem. Before Pagaya, she served as the CMO of JPMorgan Chase, where her responsibilities included leading firmwide marketing strategy for brand media, advertising, digital marketing, sponsorships, and customer research and insights. Before CMO, Mrs. Gillin was President of the Chase Co-Brand Cards Portfolio, where she grew the portfolio to the largest of its kind in the world. Before JPMorgan Chase, Mrs. Gillin was the CMO of Citibank’s Global Consumer Bank, accountable for driving business growth across 18 countries. Mrs. Gillin has also held executive roles at Citigroup, Bank of America, and MBNA. She was named a Top 25 CMO to Watch by Business Insider in 2020.
“I couldn’t be more excited to join the Board of Establishment Labs,” said Leslie Gillin. “Having highly differentiated products that deliver a much better patient experience in an industry that has been commoditized affords us opportunities to market in ways that have not been previously possible,” she continued. “Our minimally invasive technologies are also a wholly unique opportunity that will allow us to increase the market significantly and to improve the health and lives of women around the world. Direct to consumer strategies and financing programs are going to be essential to unlocking the potential of these new technologies.”
About Establishment Labs
Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving women’s health and wellness. The company’s initial focus is breast health, principally breast aesthetics and reconstruction. Establishment Labs offers a portfolio of advanced silicone gel-filled breast implants, branded as Motiva Implants that include several innovative and patented features designed to deliver improved aesthetic and clinical outcomes.
For more information: https://establishmentlabs.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.